comparemela.com

Latest Breaking News On - கிருஷ்ணன் தாஸ் - Page 15 : comparemela.com

Exclusive: India unlikely to resume sizable COVID-19 vaccine exports until October

Exclusive: India unlikely to resume sizable COVID-19 vaccine exports until October
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

India s Biological E to make J&J vaccine alongside own shot, managing director says

India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, its managing director told Reuters on Tuesday, which could boost the country's overall supplies amid a shortage.

Exclusive-India unlikely to resume sizable COVID-19 vaccine exports until October -sources

Exclusive-India unlikely to resume sizable COVID-19 vaccine exports until October -sources By Rupam Jain, Neha Arora and Krishna N. Das Reuters NEW DELHI (Reuters) - India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for domestic use, three government sources said, a longer-than-expected delay set to worsen supply shortages from the global COVAX initiative. Battling the world s biggest jump in coronavirus infections, India halted vaccine exports a month ago after donating or selling more than 66 million doses. The move has left countries including Bangladesh, Nepal, Sri Lanka and many in Africa scrambling for alternate supplies.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.